[go: up one dir, main page]

SE0400522D0 - A medical solution, a method for producing said medical solution and use thereof - Google Patents

A medical solution, a method for producing said medical solution and use thereof

Info

Publication number
SE0400522D0
SE0400522D0 SE0400522A SE0400522A SE0400522D0 SE 0400522 D0 SE0400522 D0 SE 0400522D0 SE 0400522 A SE0400522 A SE 0400522A SE 0400522 A SE0400522 A SE 0400522A SE 0400522 D0 SE0400522 D0 SE 0400522D0
Authority
SE
Sweden
Prior art keywords
medical solution
producing
present
solution
medical
Prior art date
Application number
SE0400522A
Other languages
English (en)
Inventor
Ola Carlsson
Martin Erixon
Gunita Forsbaeck
Per Kjellstrand
Torbjoern Linden
Anders Wieslander
Original Assignee
Gambro Lundia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab
Priority to SE0400522A priority Critical patent/SE0400522D0/sv
Publication of SE0400522D0 publication Critical patent/SE0400522D0/sv
Priority to PCT/SE2005/000238 priority patent/WO2005082378A1/en
Priority to CA002548770A priority patent/CA2548770A1/en
Priority to EP05711098A priority patent/EP1722800A1/en
Priority to CNA2005800017730A priority patent/CN1964721A/zh
Priority to KR1020067017626A priority patent/KR20060130190A/ko
Priority to AU2005216840A priority patent/AU2005216840A1/en
Priority to US10/591,232 priority patent/US20070232796A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
SE0400522A 2004-03-01 2004-03-01 A medical solution, a method for producing said medical solution and use thereof SE0400522D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0400522A SE0400522D0 (sv) 2004-03-01 2004-03-01 A medical solution, a method for producing said medical solution and use thereof
PCT/SE2005/000238 WO2005082378A1 (en) 2004-03-01 2005-02-22 A medical solution, a method for producing said medical solution and use thereof
CA002548770A CA2548770A1 (en) 2004-03-01 2005-02-22 A medical solution, a method for producing said medical solution and use thereof
EP05711098A EP1722800A1 (en) 2004-03-01 2005-02-22 A medical solution, a method for producing said medical solution and use thereof
CNA2005800017730A CN1964721A (zh) 2004-03-01 2005-02-22 医用溶液、所述医用溶液的生产方法及其用途
KR1020067017626A KR20060130190A (ko) 2004-03-01 2005-02-22 의료용 용액, 그 의료용 용액의 제법 및 그 의료용 용액의용도
AU2005216840A AU2005216840A1 (en) 2004-03-01 2005-02-22 A medical solution, a method for producing said medical solution and use thereof
US10/591,232 US20070232796A1 (en) 2004-03-01 2005-02-22 Medical Solution, a Method for Producing Said Medical Solution and Use Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400522A SE0400522D0 (sv) 2004-03-01 2004-03-01 A medical solution, a method for producing said medical solution and use thereof

Publications (1)

Publication Number Publication Date
SE0400522D0 true SE0400522D0 (sv) 2004-03-01

Family

ID=32067297

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400522A SE0400522D0 (sv) 2004-03-01 2004-03-01 A medical solution, a method for producing said medical solution and use thereof

Country Status (8)

Country Link
US (1) US20070232796A1 (sv)
EP (1) EP1722800A1 (sv)
KR (1) KR20060130190A (sv)
CN (1) CN1964721A (sv)
AU (1) AU2005216840A1 (sv)
CA (1) CA2548770A1 (sv)
SE (1) SE0400522D0 (sv)
WO (1) WO2005082378A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014013885A1 (de) * 2014-09-18 2016-03-24 Fresenius Medical Care Deutschland Gmbh Dialyselösung
JP2025516930A (ja) * 2022-11-03 2025-05-30 エヌ－セル カンパニー リミテッド 金属化合物を用いた過酢酸の分解促進方法及びこれを用いた微生物の培養方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310515A (en) * 1978-05-30 1982-01-12 Bristol-Myers Company Pharmaceutical compositions of cisplatin
IT1214872B (it) * 1984-04-06 1990-01-18 Mariano Feriani Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso.
AU6775787A (en) * 1985-12-20 1987-07-15 Veech, R.L. Preparation of electrolyte solutions and containers
DE3917251A1 (de) * 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
DE19748290B8 (de) * 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
DE19912850B4 (de) * 1999-03-22 2005-04-07 Fresenius Medical Care Deutschland Gmbh Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung
US6309673B1 (en) * 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
ITMI20020516A1 (it) * 2002-03-12 2003-09-12 Gambro Lundia Ab Liquidi per dialisi peritoneale emodialisi e reintegrazione

Also Published As

Publication number Publication date
KR20060130190A (ko) 2006-12-18
WO2005082378A1 (en) 2005-09-09
AU2005216840A1 (en) 2005-09-09
CN1964721A (zh) 2007-05-16
CA2548770A1 (en) 2005-09-09
US20070232796A1 (en) 2007-10-04
EP1722800A1 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
NL300933I2 (nl) Letermovir
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
EA200802213A1 (ru) Способы лечения заболеваний крови
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
TNSN05244A1 (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
NO20076405L (no) Anvendelse av 24-nor-UDCA
UA92894C2 (ru) Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
NO20070351L (no) Materialer og fremgangsmater for forbedring av skalldyrhelse, -immunitet og -vekst
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
WO2007016352A3 (en) Oral liquid losartan compositions
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
WO2006041409A8 (en) Medical solution, method for producing and use thereof
SE0400522D0 (sv) A medical solution, a method for producing said medical solution and use thereof
WO2004060902A3 (en) Novel nucleoside transport inhibitors